Published 5 days ago • loading... • Updated 4 days ago

PROREIT ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS

Nektar Therapeutics reported a fourth-quarter revenue of $29.2 million for 2024, up from $23.9 million in the previous year, with total operating costs decreasing significantly to $14.8 million from $57.4 million.
Nektar's cash and marketable securities totaled $269.1 million on December 31, 2024, down from $329.4 million a year earlier.
Howard W. Robin, President and CEO of Nektar, stated that they are on track to report topline data for rezpegaldesleukin in 2025.
Nektar's net loss for 2024 was $119.0 million, a decrease from a loss of $276.1 million in the previous year.

Insights by Ground AI

Does this summary seem wrong?

85 Articles

All

Left

Center

Right

Joplin Globe

WM Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--Mar 13, 2025-

4 days ago

Read Full Article

The Berkshire Eagle

+22 Reposted by 22 other sources

FGI INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS CONFERENCE CALL DATE

EAST HANOVER, N.J., March 13, 2025 /PRNewswire/ -- FGI Industries Ltd. (Nasdaq: FGI) ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced that it will issue financial results for the fourth quarter and full-year…

4 days ago

Read Full Article

The State Journal

+12 Reposted by 12 other sources

Vuzix Reports 4Q and Full Year 2024 Financial Results

ROCHESTER, N.Y., March 13, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI) ("Vuzix" or the "Company"), a leading supplier of AI-driven smart glasses, waveguides and Augmented Reality (AR) technologies, today reported its fourth quarter and full year financial results for the…

4 days ago

Read Full Article

The Herald Journal

Purple Innovation Reports Fourth Quarter and Full Year 2024 Results

Returned to Positive Adjusted EBITDA and Cash Flow in Fourth Quarter

4 days ago

Read Full Article

Tucson

+16 Reposted by 16 other sources

Docusign Announces Fourth Quarter and Fiscal Year 2025 Financial Results

SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Docusign, Inc. (NASDAQ: DOCU) today announced results for its fourth quarter and fiscal year ended January 31, 2025. Prepared remarks and the news release with the financial results will be accessible on Docusign's…

4 days ago·Tucson, United States

Read Full Article

Simcoe.com

Mount Logan Capital Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results

Generated $15.3 million of insurance segment Spread Related Earnings (“SRE”) for the year ended December 31, 2024, a significant increase over the prior year period

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year